Collegium Pharmaceutical (COLL) Work In Process (2016 - 2025)

Collegium Pharmaceutical's Work In Process history runs 10 years deep, the most recent figure standing at $11.6 million for Q3 2025.

• In Q3 2025, Work In Process fell 33.12% year-over-year to $11.6 million; the TTM figure through Sep 2025 stood at $11.6 million (down 33.12% YoY), while the FY2024 annual figure was $13.2 million, up 95.3% from the prior year.
• Work In Process was $11.6 million for Q3 2025 at Collegium Pharmaceutical, down from $12.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $46.4 million in Q2 2022 to a low of $802000.0 in Q1 2021.
• Historically, Work In Process has averaged $14.1 million across 5 years, with a median of $11.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Work In Process soared 4252.49% in 2022, then sank 83.92% in 2023.
• A 5-year view of Work In Process shows it stood at $1.0 million in 2021, then soared by 2350.05% to $24.7 million in 2022, then slumped by 72.68% to $6.7 million in 2023, then soared by 95.3% to $13.2 million in 2024, then declined by 11.65% to $11.6 million in 2025.
• The last three Work In Process figures came in at $11.6 million (Q3 2025), $12.1 million (Q2 2025), and $11.6 million (Q1 2025), per Business Quant data.